PDL BioPharma, Inc. Free Cash Flow per Share

Free Cash Flow per Share of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Free Cash Flow per Share growth rates and interactive chart. Free cash flow per share. Calculated as operating cash flow minus capital expenditures and divided by the weighted average number of shares outstanding. Free cash flow is the cash flow available to all the investors in a company, including common stockholders, preferred shareholders, and lenders. It is usually used in discounted cash flow models to determine a company's intrinsic value.


Highlights and Quick Summary

  • Free Cash Flow per Share for the quarter ending June 29, 2020 was -0.18 (a 40.51% increase compared to previous quarter)
  • Year-over-year quarterly Free Cash Flow per Share decreased by -168.45%
  • Annual Free Cash Flow per Share for 2019 was 0.42 (a 51.47% increase from previous year)
  • Annual Free Cash Flow per Share for 2018 was 0.27 (a -70.88% decrease from previous year)
  • Annual Free Cash Flow per Share for 2017 was 0.94 (a 34.62% increase from previous year)
  • Twelve month Free Cash Flow per Share ending June 29, 2020 was -0.06 (a -84.28% decrease compared to previous quarter)
  • Twelve month trailing Free Cash Flow per Share decreased by -110.15% year-over-year
Trailing Free Cash Flow per Share for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-0.06 -0.38 0.59 0.58
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Free Cash Flow per Share of PDL BioPharma, Inc.

Most recent Free Cash Flow per Shareof PDLI including historical data for past 10 years.

Interactive Chart of Free Cash Flow per Share of PDL BioPharma, Inc.

PDL BioPharma, Inc. Free Cash Flow per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -0.18 -0.12
2019 0.01 0.26 0.18 -0.02 0.42
2018 0.13 0.05 0.2 -0.1 0.27
2017 0.1 0.15 0.27 0.41 0.94
2016 0.25 -0.32 0.1 0.67 0.7
2015 0.64 -0.2 0.52 0.45 1.41
2014 0.15 0.68 0.55 0.61 1.98
2013 -1.29 0.33 0.79 0.38 0.2
2012 0.39 0.26 0.75 0.13 1.52
2011 0.32 0.26 0.72 -0.09 1.22
2010 0.24 0.24 0.81 1.46

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.